Literature DB >> 15001271

Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.

Hasan Murshed1, H Helen Liu, Zhongxing Liao, Jerry L Barker, Xiaochun Wang, Susan L Tucker, Anurag Chandra, Thomas Guerrero, Craig Stevens, Joe Y Chang, Melinda Jeter, James D Cox, Ritsuko Komaki, Radhe Mohan, Joe Y Change.   

Abstract

PURPOSE: To investigate dosimetric improvements with respect to tumor-dose conformity and normal tissue sparing using intensity-modulated radiotherapy (IMRT) compared with three-dimensional conformal radiotherapy (3D-CRT) for advanced-stage non-small-cell lung cancer (NSCLC). METHODS AND MATERIALS: Forty-one patients with Stage III-IV and recurrent NSCLC who previously underwent 3D-CRT were included. IMRT plans were designed to deliver 63 Gy to 95% of the planning target volume using nine equidistant coplanar 6-MV beams. Inverse planning was performed to minimize the volumes of normal lung, heart, esophagus, and spinal cord irradiated above their tolerance doses. Dose distributions and dosimetric indexes for the tumors and critical structures in both plans were computed and compared.
RESULTS: Using IMRT, the median absolute reduction in the percentage of lung volume irradiated to >10 and >20 Gy was 7% and 10%, respectively. This corresponded to a decrease of >2 Gy in the total lung mean dose and of 10% in the risk of radiation pneumonitis. The volumes of the heart and esophagus irradiated to >40-50 Gy and normal thoracic tissue volume irradiated to >10-40 Gy were reduced using the IMRT plans. A marginal increase occurred in the spinal cord maximal dose and lung volume >5 Gy in the IMRT plans, which could be have resulted from the significant increase in monitor units and thus leakage dose in IMRT.
CONCLUSION: IMRT planning significantly improved target coverage and reduced the volume of normal lung irradiated above low doses. The spread of low doses to normal tissues can be controlled in IMRT with appropriately selected planning parameters. The dosimetric benefits of IMRT for advanced-stage non-small-cell lung cancer must be evaluated further in clinical trials.

Entities:  

Mesh:

Year:  2004        PMID: 15001271     DOI: 10.1016/j.ijrobp.2003.09.086

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  66 in total

Review 1.  Volumetric modulated arc therapy: a review of current literature and clinical use in practice.

Authors:  M Teoh; C H Clark; K Wood; S Whitaker; A Nisbet
Journal:  Br J Radiol       Date:  2011-11       Impact factor: 3.039

Review 2.  Technological advances in radiotherapy for esophageal cancer.

Authors:  Milan Vosmik; Jiri Petera; Igor Sirak; Miroslav Hodek; Petr Paluska; Jiri Dolezal; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2010-11-28       Impact factor: 5.742

Review 3.  Intensity-Modulated Radiotherapy versus 3-Dimensional Conformal Radiotherapy Strategies for Locally Advanced Non-Small-Cell Lung Cancer.

Authors:  Uğur Selek; Yasemin Bölükbaşı; James W Welsh; Erkan Topkan
Journal:  Balkan Med J       Date:  2014-09-13       Impact factor: 2.021

4.  Comparison of intensity-modulated radiotherapy planning based on manual and automatically generated contours using deformable image registration in four-dimensional computed tomography of lung cancer patients.

Authors:  Elisabeth Weiss; Krishni Wijesooriya; Viswanathan Ramakrishnan; Paul J Keall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-19       Impact factor: 7.038

Review 5.  A review of intensity-modulated radiation therapy.

Authors:  Laurie E Gaspar; Meisong Ding
Journal:  Curr Oncol Rep       Date:  2008-07       Impact factor: 5.075

Review 6.  The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer.

Authors:  Zhengfei Zhu; Xiaolong Fu
Journal:  Transl Lung Cancer Res       Date:  2015-06

7.  Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.

Authors:  Jingbo Wang; Zongmei Zhou; Jun Liang; Qinfu Feng; Zefen Xiao; Zhouguang Hui; Xiaozhen Wang; Jima Lv; Dongfu Chen; Hongxing Zhang; Zhe Ji; Jianzhong Cao; Lipin Liu; Wei Jiang; Yu Men; Cai Xu; Jiangrong Dai; Weibo Yin; Luhua Wang
Journal:  Oncologist       Date:  2016-09-14

8.  Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Authors:  Sonal Sura; Vishal Gupta; Ellen Yorke; Andrew Jackson; Howard Amols; Kenneth E Rosenzweig
Journal:  Radiother Oncol       Date:  2008-03-17       Impact factor: 6.280

9.  Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Authors:  Anhui Shi; Guangying Zhu; Hao Wu; Rong Yu; Fuhai Li; Bo Xu
Journal:  Radiat Oncol       Date:  2010-05-12       Impact factor: 3.481

10.  Feasibility of image registration and intensity-modulated radiotherapy planning with hyperpolarized helium-3 magnetic resonance imaging for non-small-cell lung cancer.

Authors:  Rob H Ireland; Chris M Bragg; Mark McJury; Neil Woodhouse; Stan Fichele; Edwin J R van Beek; Jim M Wild; Matthew Q Hatton
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-05-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.